These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2206955)

  • 21. Enzyme-linked immunosorbent assay (ELISA) for human epidermal growth factor (hEGF).
    Abe Y; Sagawa T; Sakai K; Kimura S
    Clin Chim Acta; 1987 Sep; 168(1):87-95. PubMed ID: 3499262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR.
    Reilly RM; Kiarash R; Cameron RG; Porlier N; Sandhu J; Hill RP; Vallis K; Hendler A; Gariépy J
    J Nucl Med; 2000 Mar; 41(3):429-38. PubMed ID: 10716315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary excretion of human epidermal growth factor (hEGF) in patients with malignant tumors.
    Uchihashi M; Hirata Y; Nakajima H; Fujita T; Matsukura S
    Horm Metab Res; 1983 May; 15(5):261-2. PubMed ID: 6603405
    [No Abstract]   [Full Text] [Related]  

  • 24. Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor: an auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer.
    Reilly RM; Chen P; Wang J; Scollard D; Cameron R; Vallis KA
    J Nucl Med; 2006 Jun; 47(6):1023-31. PubMed ID: 16741313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dynamics of urinary excretion of cyclic nucleotides in cancer patients during a long-term follow-up].
    Bershteĭn LM
    Vopr Onkol; 1987; 33(9):54-8. PubMed ID: 2821698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A sensitive two-site enzyme immunoassay for human epidermal growth factor (urogastrone).
    Hayashi K; Nomoto H; Kurobe M; Nishimuro S; Hiratani H; Furukawa S
    Biochem Int; 1985 Jun; 10(6):839-45. PubMed ID: 3899115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urine human epidermal growth factor (hEGF) levels following surgery.
    Abe Y; Miyake M; Sagawa T; Kimura S
    Jpn J Surg; 1988 Nov; 18(6):641-6. PubMed ID: 3266767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
    Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
    BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer.
    Reilly RM; Kiarash R; Sandhu J; Lee YW; Cameron RG; Hendler A; Vallis K; Gariépy J
    J Nucl Med; 2000 May; 41(5):903-11. PubMed ID: 10809207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a human epidermal growth factor derivative with EGFR-blocking and depleted biological activities: A comparative in vitro study using EGFR-positive breast cancer cells.
    Mehrabi M; Mansouri K; Soleymani B; Hoseinkhani Z; Shahlaie M; Khodarahmi R
    Int J Biol Macromol; 2017 Oct; 103():275-285. PubMed ID: 28501600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Urinary epidermal growth factor and serum pepsinogen I in patients with duodenal ulcers].
    Kolster J; de Kolster CC; Carvajal A; Castro J; González E; Brasel JA; Callegari C
    G E N; 1993; 47(1):16-21. PubMed ID: 8243967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of a high-molecular-weight form of epidermal growth factor in an extract of human urine.
    Mount CD; Lukas TJ; Orth DN
    Arch Biochem Biophys; 1987 May; 255(1):1-7. PubMed ID: 3496043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of cripto-1 as a novel serologic marker for breast and colon cancer.
    Bianco C; Strizzi L; Mancino M; Rehman A; Hamada S; Watanabe K; De Luca A; Jones B; Balogh G; Russo J; Mailo D; Palaia R; D'Aiuto G; Botti G; Perrone F; Salomon DS; Normanno N
    Clin Cancer Res; 2006 Sep; 12(17):5158-64. PubMed ID: 16951234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of non-biologically active truncated EGF (EGFt) and full-length hEGF for delivery of Auger electron-emitting 111In to EGFR-positive breast cancer cells and tumor xenografts in athymic mice.
    Panosa C; Fonge H; Ferrer-Batallé M; Menéndez JA; Massaguer A; De Llorens R; Reilly RM
    Nucl Med Biol; 2015 Dec; 42(12):931-8. PubMed ID: 26385534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of low-dose prophylactic dopamine on high-dose cisplatin-induced electrolyte wasting, ototoxicity, and epidermal growth factor excretion: a randomized, placebo-controlled, double-blind trial.
    Somlo G; Doroshow JH; Lev-Ran A; Ahn DC; Hwang L; Raschko JW; Forman SJ; Margolin KA; Morgan RJ; Leong LA
    J Clin Oncol; 1995 May; 13(5):1231-7. PubMed ID: 7738626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulation of chondrocytes in vitro by gene transfer with plasmids coding for epidermal growth factor (hEGF) and basic fibroblast growth factor (bFGF).
    Schmal H; Mehlhorn AT; Zwingmann J; Müller CA; Stark GB; Südkamp NP
    Cytotherapy; 2005; 7(3):292-300. PubMed ID: 16081356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reassessment of the two-site enzyme immunoassay for human epidermal growth factor (hEGF) and measurement of immunoreactive hEGF in human sera and urine.
    Takei Y; Kurobe M; Ezawa H; Hayashi K
    J Clin Lab Anal; 1995; 9(2):107-12. PubMed ID: 7714662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of urinary excretion of modified nucleosides.
    Gehrke CW; Kuo KC; Waalkes TP; Borek E
    Cancer Res; 1979 Apr; 39(4):1150-3. PubMed ID: 421198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
    Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
    Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of CD137 and CD137 ligand in colorectal cancer patients.
    Dimberg J; Hugander A; Wågsäter D
    Oncol Rep; 2006 May; 15(5):1197-200. PubMed ID: 16596186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.